🇨🇭#RO #отчетность
Roche Q4, FY 22 Earnings:
- Rev CHF16.24B (est CHF16.12B)
- Diagnostics Sales CHF3.88B (est CHF3.79B)
- FY Sales CHF63.28B (est CHF63.29B)
- FY Core EPS CHF20.30 (est CHF20.61)
- Sees 2023 Sales Fall In Low Single Digits At Constant FX
Roche Q4, FY 22 Earnings:
- Rev CHF16.24B (est CHF16.12B)
- Diagnostics Sales CHF3.88B (est CHF3.79B)
- FY Sales CHF63.28B (est CHF63.29B)
- FY Core EPS CHF20.30 (est CHF20.61)
- Sees 2023 Sales Fall In Low Single Digits At Constant FX